SynthesisInternational journal of clinical pharmacy2019

Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis.

Sara Kaveh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.